ABSTRACT
The Publisher regrets that this article is an accidental duplication of an article that has already been published in Journal of Cardiothoracic and Vascular Anesthesia, 36 (2022) 2793-2802, http://dx.doi.org/10.1053/j.jvca.2021.10.030. The duplicate article has therefore been withdrawn. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.
Subject(s)
Carcinoid Heart Disease , Heart Valve Diseases , Carcinoid Heart Disease/diagnosis , Carcinoid Heart Disease/diagnostic imaging , Echocardiography , HumansABSTRACT
No disponible
Subject(s)
Humans , Male , Adult , Hepatectomy/methods , Hemangioma/complications , Hemangioma/surgery , Tamoxifen/therapeutic use , Abdomen/pathology , Abdomen , Abdominal Neoplasms/pathology , Abdominal Neoplasms/surgery , Abdominal NeoplasmsSubject(s)
Hemangioma, Cavernous/surgery , Hepatectomy/methods , Liver Neoplasms/surgery , Adult , Disease Progression , Estrogens/biosynthesis , Estrogens/physiology , Hemangioma, Cavernous/etiology , Hemangioma, Cavernous/pathology , Humans , Liver Neoplasms/etiology , Liver Neoplasms/pathology , MaleABSTRACT
BACKGROUND: Bariatric surgery patients are at risk of perioperative airway collapse. Neuromuscular blockade should be fully reversed before tracheal extubation. The optimal dosage of the reversal agent sugammadex in the morbidly obese is still unknown. This study explored the sugammadex dose adjusted according to train-of-four ratio (TOFR). METHODS: Prospective observational study of consecutive patients scheduled for laparoscopic bariatric surgery. To reverse a deep blockade (2 or fewer posttetanic twitches), a dose of sugammadex of 4 mg/kg ideal body weight (IBW) was followed by a second dose of 2 mg/kg IBW if the TOFR was less than 0.9 after 3 min. To reverse a moderate blockade (reappearance of the second twitch in the TOF), a 2 mg/kg IBW dose of sugammadex was followed by a second dose of 2 mg/kg IBW if the TOFR was less than 0.9 after 2 min. Sugammadex effectiveness was reflected by the time required to obtain a TOFr of 0.9 or more. RESULTS: A total of 120 patients were included. The blockade was deep at the end of surgery in 43 and moderate in 77. The median times (range) to TOFR of 0.9 or more were 167 (20-460) seconds and 113 (28-300) seconds in deep and moderate blockades, respectively (P < 0.05). The percentage of patients requiring a second dose of sugammadex were larger after deep blockades (39.5% [n = 17] vs. 23.4% [n = 18] after moderate blockades); the difference was not significant. CONCLUSION: A sugammadex dose calculated according to IBW is insufficient for reversing both deep and moderate blockades in morbidly obese patients.
